HNW
EW icon

High Note Wealth’s Edwards Lifesciences EW Stock Holding History

High Note Wealth’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.32K Buy
92
+53
+136% +$4.44K ﹤0.01% 450
2026
Q1 		$3.12K Buy
39
+8
+26% +$660 ﹤0.01% 698
2025
Q4 		$2.64K Sell
31
-20
-39% -$1.64K ﹤0.01% 693
2025
Q3 		$3.97K Sell
51
-50
-50% -$3.91K ﹤0.01% 568
2025
Q2 		$7.9K Sell
101
-5
-5% -$373 ﹤0.01% 328
2025
Q1 		$7.68K Sell
106
-2
-2% -$143 ﹤0.01% 324
2024
Q4 		$8K Buy
+108
New +$7.56K ﹤0.01% 326

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

High Note Wealth's EW Position: Q2 2026 in Review

High Note Wealth increased its Edwards Lifesciences (EW) stake by 136% in Q2 2026, buying an estimated $4.44K and bringing the position to 92 shares worth $8.32K. The position accounts for ﹤0.01% of the portfolio, ranked #450.

High Note Wealth first reported a position in EW in Q4 2024 and has held it in 7 quarters since. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • High Note Wealth held 92 shares of Edwards Lifesciences worth $8.32K as of Q2 2026.
  • High Note Wealth bought 53 Edwards Lifesciences shares in Q2 2026, an estimated $4.44K.
  • Edwards Lifesciences made up ﹤0.01% of High Note Wealth's portfolio in Q2 2026, its #450 holding.
  • High Note Wealth first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 7 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on High Note Wealth's 13F filing for Q2 2026, filed 23 Jul 2026.